Loading…
Starting the journey: Understanding the roles of complement proteins in liver diseases through mendelian randomization
[...]Mendelian randomization (MR) serves as a method for causal inference using observational data and single nucleotide polymorphisms as instrumental variables to infer causal relationships. [19] in a recently published paper assessed the causal association between 28 circulating complement compone...
Saved in:
Published in: | Clinical and molecular hepatology 2024, 30(2), , pp.150-153 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | [...]Mendelian randomization (MR) serves as a method for causal inference using observational data and single nucleotide polymorphisms as instrumental variables to infer causal relationships. [19] in a recently published paper assessed the causal association between 28 circulating complement components and CLDs, including alcohol-related cirrhosis (ALC), MASLD, and three major autoimmune liver diseases, namely AIH, primary sclerosing cholangitis (PSC), primary biliary cholangitis (PBC), and HCC, through two-sample MR. In this study, the authors found a significant association between genetically predicted complement component levels of C1q C chain (C1QC) with AIH, C8 gamma chain (C8G) and complement factor H-related protein 5 (CFHR5) with PSC, CFHR1, CFHR2, and C1QC with ALC, C8G with MASLD, and finally CFHR2, C7, and C15 with HCC using the inverse-variance weighted (IVW) method. [...]future studies should confirm the association using other available GWAS data from other ancestries to confirm the generalizability of the results in a wider population with different ethnic backgrounds. Abbreviations CLD, chronic liver diseases; AIH, autoimmune hepatitis; ALC, alcohol-related cirrhosis; ALD, alcohol-associated liver disease; PSC, primary sclerosing cholangitis; PBC, primary biliary cholangitis; HCC, hepatocellular carcinoma; MASLD, metabolic dysfunction-associated steatotic liver disease; CFHR, complement factor H-related protein; C8G, complement C8 gamma chain; GWAS, genome-wide association study; WM, weighted median; IVW, inverse-variance weighted; MR, mendelian randomization; OR, odds ratio; CI, confidence interval 1. |
---|---|
ISSN: | 2287-2728 2287-285X 2287-285X |
DOI: | 10.3350/cmh.2024.0116 |